Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Novavax Inc (NVAX)  
$0.36 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 118,790,000
Market Cap: 42.71(M)
Last Volume: 19,275,386 Avg Vol: 9,179,628
52 Week Range: $0.3595 - $0.3595
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Novavax is a biotechnology company that promotes improved global health through the discovery, development and commercialization of vaccines to prevent serious infectious diseases. Co.'s vaccine candidates, including both its coronavirus vaccine candidate, NVX-CoV2373, and its primary influenza vaccine candidate, NanoFlu, are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 and NanoFlu include the use of Co.'s proprietary Matrix-M™ adjuvant.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 6,000
Total Buy Value $0 $0 $0 $43,042
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 3
Total Shares Sold 0 0 0 12,500
Total Sell Value $0 $0 $0 $919,765
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 151
  Page 2 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Glenn Gregory M SVP, Research and Development   •       –      –    2014-03-14 4 S $5.48 $158,778 D/D (29,000) 4,102     -
   Glenn Gregory M SVP, Research and Development   •       –      –    2014-03-14 4 GD $0.00 $0 D/D 2,000 33,102     -
   Glenn Gregory M SVP, Research and Development   •       –      –    2014-01-31 4 B $2.29 $9,394 D/D 4,102 31,000 2.74     -
   Wilson Russell P SVP, Business Development   •       –      –    2014-01-31 4 B $2.29 $11,221 D/D 4,900 54,900 2.74     -
   Hahn Timothy Jon SVP, Manufacturing & PD   •       –      –    2014-01-31 4 B $2.29 $21,563 D/D 9,416 80,416 2.74     -
   Phillips Barclay A SVP, Chief Financial Officer   •       –      –    2014-01-31 4 B $2.29 $22,598 D/D 9,868 9,868 2.74     -
   Erck Stanley C President and CEO   •       •      –    2014-01-31 4 B $2.29 $27,178 D/D 11,868 74,868 2.81     -
   Phillips Barclay A SVP, Chief Financial Officer   •       –      –    2013-06-12 4/A B $0.00 $0 D/D 0 0 2.66     -
   Phillips Barclay A Director   –       •      –    2013-06-12 4 B $1.90 $95,000 D/D 50,000 200,000 2.39     -
   Douglas Richard Director   –       •      –    2013-06-12 4 B $1.90 $95,000 D/D 50,000 200,000 2.39     -
   Hahn Timothy Jon SVP, Manufacturing & PD   •       –      –    2013-06-10 4 B $1.88 $39,480 D/D 21,000 71,000 2.74     -
   Glenn Gregory M Chief Scientific Officer   •       –      –    2013-06-07 4 B $1.83 $1,830 D/D 1,000 31,000 2.66     -
   Glenn Gregory M Chief Scientific Officer   •       –      –    2013-06-06 4 B $2.01 $2,010 D/D 1,000 30,000 2.66     -
   Young James F Director   –       •      –    2013-06-06 4 B $1.91 $191,000 D/D 100,000 400,000 2.39     -
   Evans Gray C Director   –       •      –    2013-04-24 4 S $2.44 $193,540 D/D (79,000) 702,558     -
   Young James F Director   –       •      –    2013-03-11 4 B $2.03 $203,000 D/D 100,000 300,000 2.39     -
   Hahn Timothy Jon SVP, Manufacturing & PD   •       –      –    2012-05-14 4 B $1.33 $39,900 D/D 30,000 50,000 2.74     -
   Glenn Gregory M Chief Scientific Officer   •       –      –    2012-05-10 4 B $1.35 $33,750 D/D 25,000 29,000 2.74     -
   Douglas Richard Director   –       •      –    2012-04-10 4 B $1.21 $60,500 D/D 50,000 200,000 2.39     -
   Glenn Gregory M Chief Scientific Officer   •       –      –    2011-12-05 4 B $1.50 $3,000 D/D 2,000 418,000 2.66     -
   Young James F Director   –       •      –    2011-12-01 4 B $1.46 $292,000 D/D 200,000 440,000 2.39     -
   Wilson Russell P SVP, Business DevelopmentOffic   •       –      –    2011-12-01 3 IO $0.00 $0 D/D 0 50,000     -
   Glenn Gregory M Chief Scientific Officer   •       –      –    2011-11-29 4 B $1.26 $2,520 D/D 2,000 416,000 2.66     -
   Hahn Timothy Jon SVP, Manufacturing & PDOfficer   •       –      –    2011-09-22 3 IO $0.00 $0 D/D 0 20,000     -
   Evans Gray C Director   –       •      –    2011-08-23 4/A S $1.22 $581,423 D/D (476,576) 773,878     -

  151 Records found
  1  2  3  4  5  6  7   
  Page 2 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed